South Korea has recorded its first case of blood clotting linked to the AstraZeneca Covid-19 vaccine, with one man being hospitalized.
Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong revealed on Monday that an unnamed man in his 30s had to be hospitalized for a power headache and muscle cramps after he became once vaccinated on April 27.
“His situation has improved since then and we perceive there is now not this form of thing as a great announce though he restful needs monitoring,” Jeong added.
South Korea for the time being uses AstraZeneca, Pfizer, Johnson & Johnson, and Moderna vaccines in its vaccination program. Over 4,600,000 doses of these vaccines were administered within the nation.
Two weeks ago, South Korea introduced that it would possibly per chance per chance well well trial the mixing of AstraZeneca and Pfizer vaccines so as to bustle up vaccination.
AstraZeneca’s vaccine, typically diagnosed as Vaxzevria, has been linked to a assortment of circumstances of with out doubt fatal blood clotting in all across the enviornment, with deaths recorded in Canada, the UK, Norway, Slovakia, and beyond.
Consequently, the vaccine has been suspended in quite so a lot of countries and restricted to these in older age brackets – whose safe the reduction of the jab is deemed to outweigh the risk – in other countries.
On top of hyperlinks to deadly blood clotting, the European Medicines Agency (EMA) has also been investigating studies of AstraZeneca’s vaccine causing Guillain-Barre syndrome.
Since the beginning of the pandemic, South Korea has recorded almost 140,000 circumstances of Covid-19 and 1,957 deaths.
Ponder your chums could well be alive to? Half this yarn!